01 / BIOCHIP
Biochip Development
High-sensitivity biosensors and microfluidic chips tailored for IVD clinical scenarios.
R&D CAPABILITY
R&D Strength
An international academic foundation and an industry-grade R&D system, bringing together experts and scholars from the world's top universities and research institutes, dedicated to forward-looking, disruptive, and strategic technology development and reserves.
The R&D team conducts systematic technology development and reserves across underlying materials, devices, and detection methods.
R&D SYSTEM
Global Academic Foundation and Industry-Grade Innovation System
The WWHS R&D team brings together experts and scholars from world-class institutions — Stanford University, Lawrence Berkeley National Laboratory, The Chinese University of Hong Kong, Peking University, Shanghai Jiao Tong University, and Southern University of Science and Technology. The team is dedicated to forward-looking, disruptive, and strategic technology development and reserves, with internationally leading capabilities in biochip development, nanomaterials fabrication, and nano-biotechnology, continuously delivering original underlying-technology capability to the company.
GLOBAL ACADEMIC NETWORK
Academic Affiliations
Our R&D team brings together scholars from the following world-renowned universities and institutions.
Stanford University
United States
Lawrence Berkeley National Laboratory
United States
The Chinese University of Hong Kong
Hong Kong, China
Peking University
China
Shanghai Jiao Tong University
China
Southern University of Science and Technology
China
Chinese Academy of Sciences
China
Massachusetts Institute of Technology (MIT)
United States
University of Chicago
United States
R&D DIRECTIONS
Three R&D Focus Areas
The team is dedicated to forward-looking, disruptive, and strategic technology development and reserves, with core focus on:
02 / NANOMATERIAL
Nanomaterials Fabrication
Customized infrared fluorescent nanospheres, quantum dots, and other core reagent materials.
03 / NANOBIOTECH
Nano-Biotechnology
Nano-probe and biomolecule conjugation technologies supporting high-sensitivity detection.
CORE TEAM
Core R&D Team
Bringing together leaders with both industry and academic backgrounds to drive technology innovation and product commercialization.
Zhongping Deng
Chairman
Ph.D., Peking University
Oversees WWHS strategic planning and Sansure Biotech Inc. resource coordination. With years of deep experience in the IVD industry, he has led R&D, supply chain, quality inspection, science & technology projects, and external cooperation, bringing extensive industry expertise and resources.
Meijie Tang
U.S. Headquarters
Ph.D., Massachusetts Institute of Technology (MIT)
Leads new technology and new product development at the U.S. headquarters. With years of entrepreneurial experience in Silicon Valley, he keeps close to the frontier of international technology products and excels at formulating forward-looking strategies for the global market.
Guoxin Wang
General Manager
Ph.D., The Chinese University of Hong Kong
Has overall responsibility for company operations. With deep industry experience, he is skilled in strategy formulation and operational management, bringing sharp insight to solve diverse development challenges.
Tao Liao
R&D Director
Ph.D., Chinese Academy of Sciences
Leads product development. With more than 10 years of IVD industry experience, he has deep expertise in IVD product development and technology improvement, with strong capability for innovation and execution.
Yongye Liang
Scientific Advisor
Ph.D., University of Chicago
Advises on product R&D. He conducts structural design, synthesis, and structure-activity relationship studies of NIR-II fluorescent organic molecules, developing long-wavelength, high-brightness fluorescent molecules for bioimaging, detection, and sensing.
PARTNER WITH WWHS
Discuss R&D Collaboration
Welcome to discuss technical collaboration with our R&D team to advance the clinical adoption of NIR-II precision detection.